IPCALAB.NS

Ipca Laboratories Limited [IPCALAB.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

IPCALAB.NS Stock Summary

Top 10 Correlated Stocks

IPCALAB.NS

In the News

IPCALAB.NS Financial details

Company Rating
-
Market Cap
339.71B
Income
5.64B
Revenue
71.86B
Book val./share
-
Cash/share
-
Dividend
2
Dividend %
0.18%
Employees
16.17K
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
57.54
Forward P/E
-
PEG
-15.91
P/S
4.24
P/B
4.61
P/C
-
P/FCF
-
Quick Ratio
1.04
Current Ratio
2.13
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
22.25
EPS next Y
-
EPS next Q
-
EPS this Y
-46.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.08%
Revenue last 5Y
11.08%
Revenue Q/Q
0.93%
EPS Q/Q
23.95%
-
-
-
-
SMA20
1.73%
SMA50
1.07%
SMA100
-9.65%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
16%
ROC
0.1%
Gross Margin
65%
Oper. Margin
13%
Profit Margin
7%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
669.8-1348.1
52W High
+9.15%
52W Low
+119.93%
RSI
61
Rel Volume
0.37
Avg Volume
563.32K
Volume
207.04K
Perf Week
7.27%
Perf Month
-1.76%
Perf Quarter
-8.45%
Perf Half Y
-6.09%
-
-
-
-
Beta
0.23
-
-
Volatility
27.2%, 42.81%
Prev Close
0.97%
Price
1471.3
Change
1.98%

IPCALAB.NS Financial Performance

IPCALAB.NS Dividend History

IPCALAB.NS Frequently Asked Questions

What is Ipca Laboratories Limited stock symbol ?

Ipca Laboratories Limited is a IN stock and trading under the symbol IPCALAB.NS

What is Ipca Laboratories Limited stock quote today ?

Ipca Laboratories Limited stock price is $1471.3 today.

Is Ipca Laboratories Limited stock public?

Yes, Ipca Laboratories Limited is a publicly traded company.

Something similar

Top by Market Cap
BRK-A
AMZ.DE
VTSAX
VTI
NVDA
Same Sector
0OCQ.L
THTX
ASMB
ZICC.ST
WBA
Top Correlated Stocks
SASKEN.NS
SWSOLAR.NS
SUMIT.NS
BIGBLOC.NS
INDOTECH.NS
Similar Market Cap
IDFCFIRSTB.NS
GFINBURO.MX
9409.T
130660.KS
000480.KS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 563.32K
  • Market Capitalization 339.71B
  • Employee 16.17K
  • CEO Mr. Pranay Premchand Godha
  • Headquarters Mumbai,IN
  • IPO Date 1996-01-01
  • Website https://www.ipca.com

Ipca Laboratories Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, dermatology, diabetology, gastroenterology, haematology, neurology, ophthalmology, rheumatology, and urology, as well as respiratory, psychiatry, probiotics, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It exports its products to approximately 100 countries worldwide. The company was incorporated in 1949 and is based in Mumbai, India.